Immunotherapy in pituitary carcinomas and aggressive pituitary tumors

Complete Response of a Patient With a Mismatch Repair Deficient Aggressive Pituitary Adenoma to Immune Checkpoint Inhibitor Therapy: A Case Report

(2022) Sanjit Shah et al.   NEUROSURGERY

Immunotherapy in aggressive pituitary tumors and carcinomas: a systematic review

(2022) Mirela Diana Ilie et al.   ENDOCRINE-RELATED CANCER

Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study

(2022) Mirela Diana Ilie et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression

(2021) Yu Mei et al.   Pituitary

PD-L1 Is Preferentially Expressed in PIT-1 Positive Pituitary Neuroendocrine Tumours

(2021) John Turchini et al.   ENDOCRINE PATHOLOGY

Response Rates to Anti–PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase

(2021) Cristina Valero et al.   JAMA Oncology

Aggressive pituitary tumours and pituitary carcinomas

(2021) Gérald Raverot et al.   Nature Reviews Endocrinology

Should pituitary carcinoma be treated using a NET‐like approach? A case of complete remission of a metastatic malignant prolactinoma with multimodal therapy including immunotherapy

(2021) Bernard Goichot et al.   CLINICAL ENDOCRINOLOGY

The adverse events associated with combination immunotherapy in cancers: Challenges and chances

(2020) Minglei Zhuo et al.   Asia-Pacific Journal of Clinical Oncology

Immune Landscape of Pituitary Neuroendocrine Tumours Reveals Association between Macrophages and Gonadotroph-Tumour Invasion

(2020) Moitza Principe et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Treatment options for gonadotroph tumors: current state and perspectives

(2020) Mirela Diana ILIE et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness

(2020) Zihao Wang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A decade of immune-checkpoint inhibitors in cancer therapy

(2020) Caroline Robert   Nature Communications

Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature

(2020) Camille Duhamel et al.   Journal of Personalized Medicine

Human immunology and immunotherapy: main achievements and challenges

(2020) Jezabel Varadé et al.   Cellular & Molecular Immunology

Aggressive Pituitary Adenomas and Carcinomas

(2020) Mirela Diana Ilie et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy

(2020) Lydia S. Lamb et al.   Frontiers in Endocrinology

Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes

(2019) Garima Yagnik et al.   Oncotarget

Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors

(2019) Sayka Barry et al.   ONCOGENE

Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab

(2019) Mario Caccese et al.   ANTI-CANCER DRUGS

Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours

(2019) Pedro Marques et al.   Acta Neuropathologica Communications

Marked response of a hypermutated adrenocorticotropic hormone-secreting pituitary carcinoma to ipilimumab and nivolumab

(2018) Andrew L Lin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas

(2017) Gerald Raverot et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors

(2016) Yu Mei et al.   Oncotarget

Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas

(2015) Jian-Qiang Lu et al.   ENDOCRINE PATHOLOGY

Tumor Infiltrating Lymphocytes But Not Serum Pituitary Antibodies Are Associated with Poor Clinical Outcome after Surgery in Patients with Pituitary Adenoma

(2009) Isabella Lupi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM